Common Contracts

SOUNDHOUND AI, INC. $150,000,000 Shares Common Stock ($ 0.0001 par value) Equity Distribution Agreement

Equity Distribution Agreement • April 10th, 2024 • Soundhound Ai, Inc. • Services-prepackaged software • New York

• Contract Type
  Equity Distribution Agreement
• Filed
  April 10th, 2024
• Company
  Soundhound Ai, Inc.
• Industry
  Services-prepackaged software
• Jurisdiction
  New York

SoundHound AI, Inc., a corporation organized under the laws of Delaware (the “Company”), confirms its agreement (this “Agreement”) with Citigroup Global Markets Inc., Barclays Capital Inc., Wedbush Securities Inc., Northland Securities, Inc. and Ladenburg Thalmann & Co. Inc. (each, a “Manager,” and, collectively, the “Managers”) as follows:

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. Common Shares (without par value) Having an Aggregate Offering Price of up to Equity Distribution Agreement

Equity Distribution Agreement • December 23rd, 2020 • Biohaven Pharmaceutical Holding Co Ltd. • Pharmaceutical preparations • New York

• Contract Type
  Equity Distribution Agreement
• Filed
  December 23rd, 2020
• Company
  Biohaven Pharmaceutical Holding Co Ltd.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Biohaven Pharmaceutical Holding Company Ltd., a British Virgin Islands business company (the “Company”), confirms its agreement (this “Agreement”) with Goldman Sachs & Co. LLC, Piper Sandler & Co. LLC, SVB Leerink LLC, Canaccord Genuity LLC, Mizuho Securities USA LLC, Wedbush Securities Inc., and William Blair & Company L.L.C. (each a “Manager” and, collectively, the “Managers”) as follows:

Apellis Pharmaceuticals, Inc. $150,000,000 Shares Common Stock ($0.0001 par value per share) Amended and Restated Equity Distribution Agreement

Equity Distribution Agreement • October 4th, 2019 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Equity Distribution Agreement
• Filed
  October 4th, 2019
• Company
  Apellis Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Reference is made to the Equity Distribution Agreement, dated as of December 28, 2018 (the “Original Agreement”), by and between Apellis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Citigroup Global Markets Inc. (“Citigroup”), pursuant to which the Company proposed to issue and sell through Citigroup, from time to time during the term of the Original Agreement, on the terms and subject to the conditions set forth in the Original Agreement, shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”). The Company, Citigroup and Jefferies LLC (“Jefferies” together with Citigroup, collectively, the “Managers”, and each individually a “Manager”) wish to amend and restate the Original Agreement in its entirety as provided hereby.